Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Meeks

Showing results (31-40 of 208) with videos related to

Pageof 21
Sort By:
Urologic Oncology|November 18, 2018
Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patientsDamiano Fantini, Roland Seiler, Joshua J Meeks
Translational Andrology and Urology|May 31, 2019
Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer?David J VanderWeele, Joshua J Meeks, Maha Hussain
Urologic Oncology|March 6, 2012
Environmental toxicology of testicular cancerJoshua J Meeks, Joel Sheinfeld, Scott E Eggener
Nature Genetics|April 8, 2003
Dax1 is required for testis determinationJoshua J Meeks, Jeffrey Weiss, J Larry Jameson
Urologic Oncology|January 19, 2020
A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuriaRichard S Matulewicz, Alfred Rademaker, Joshua J Meeks
European Urology|September 30, 2020
Reply to Fredrik Liedberg, Pontus Eriksson, and Gottfrid Sjödahl's Letter to the Editor re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol;2020:533-7Joshua J Meeks, Lars Dyrsjkøt, A Gordon Robertson
Urologic Oncology|March 4, 2020
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancerLauren Folgosa Cooley, Alexander P Glaser, Joshua J Meeks
The Journal of Urology|May 13, 2022
Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-GuérinJoshua J Meeks, Wade J Sexton, Peter E Clark
The Journal of Urology|December 19, 2008
Staged reconstruction of long segment urethral strictures in men with previous pediatric hypospadias repairJoshua J Meeks, Bradley A Erickson, Chris M Gonzalez
European Urology Oncology|June 16, 2019
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort StudyAdam B Weiner, Anuj S Desai, Joshua J Meeks
Pageof 21

Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Urologic Oncology|November 18, 2018
Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patientsDamiano Fantini, Roland Seiler, Joshua J Meeks
Translational Andrology and Urology|May 31, 2019
Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer?David J VanderWeele, Joshua J Meeks, Maha Hussain
Urologic Oncology|March 6, 2012
Environmental toxicology of testicular cancerJoshua J Meeks, Joel Sheinfeld, Scott E Eggener
Nature Genetics|April 8, 2003
Dax1 is required for testis determinationJoshua J Meeks, Jeffrey Weiss, J Larry Jameson
Urologic Oncology|January 19, 2020
A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuriaRichard S Matulewicz, Alfred Rademaker, Joshua J Meeks
European Urology|September 30, 2020
Reply to Fredrik Liedberg, Pontus Eriksson, and Gottfrid Sjödahl's Letter to the Editor re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol;2020:533-7Joshua J Meeks, Lars Dyrsjkøt, A Gordon Robertson
Urologic Oncology|March 4, 2020
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancerLauren Folgosa Cooley, Alexander P Glaser, Joshua J Meeks
The Journal of Urology|May 13, 2022
Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-GuérinJoshua J Meeks, Wade J Sexton, Peter E Clark
The Journal of Urology|December 19, 2008
Staged reconstruction of long segment urethral strictures in men with previous pediatric hypospadias repairJoshua J Meeks, Bradley A Erickson, Chris M Gonzalez
European Urology Oncology|June 16, 2019
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort StudyAdam B Weiner, Anuj S Desai, Joshua J Meeks
Pageof 21